About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

TERMINATEDPhase 1

Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults

Safety and Pharmacokinetics of Oleylphosphocholine (OlPC), Administered Orally in Healthy Adults: A Phase 1, Single Center, Open-label, Staggered, Dose-escalation Trial

NCT06124144•University Hospital Tuebingen

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Leishmaniasis

Interventions

Oleylphosphocholine

Locations

1

Germany

Locations (1)

Institute for Tropical Medicine

Tübingen, Germany

Key Dates

Start Date

June 21, 2023

Primary Completion Date

February 27, 2024

Completion Date

February 27, 2024

Last Updated

March 12, 2024

Related Studies

RECRUITINGPhase 2

Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate

NCT06798402

Cutaneous Leishmaniasis

RECRUITINGPhase 3

Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan

NCT04268524

Old World Cutaneous Leishmaniasis

Human Bioequivalence Study of Amphotericin B Liposome for Injection

NCT06977490

Invasive Fungal InfectionsNeutropenic Fever+1 more

COMPLETEDPhase 3

Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria

NCT06917040

Leishmaniasis, CutaneousVector Borne Diseases

Not Yet RecruitingPhase 3

Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.

NCT06822478

Leishmaniasis, Cutaneous

Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the Disease

NCT06692985

Cutaneous Leishmaniasis

View all related studies

Sponsors

Lead Sponsor

University Hospital Tuebingen

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 12, 2024Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions